
Glen Tullman
Managing Partner
Glen, CEO of Transcarent, leads a consumer-directed health and care platform for self-insured employers. Previously, he founded Livongo Health, which empowered people with chronic conditions and saw the largest consumer digital health IPO in history, later merging with Teladoc Health for $18.5 billion.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Health
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.